Poly-alendronate Dextran-Guanidine Conjugate

Known as: Dextran/Alendronate/Guanidine-containing Polybisphosphonate, ODX 
A polybisphosphonate dextran-guanidine conjugate with potential anti-resorptive and antineoplastic activities. Alendronic acid and aminoguanidine… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Oncotype DX (ODX) recurrence score (RS) breast cancer (BC) assay is costly, and performed in only ~1/3 of estrogen receptor (ER… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
The treatment and management of early stage estrogen receptor positive (ER+) breast cancer is hindered by the difficulty in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2016
2016
PURPOSE Oncotype DX (ODX) is a tumor gene-profiling test that aids in adjuvant chemotherapy decision-making. ODX has the… (More)
Is this relevant?
2016
2016
Early stage estrogen receptor positive (ER+) breast cancer (BCa) treatment is based on the presumed aggressiveness and likelihood… (More)
Is this relevant?
2015
2015
BACKGROUND Predicting recurrence risk and chemotherapy benefit in early-stage breast cancer can be challenging, and Oncotype DX… (More)
Is this relevant?
2015
2015
CONTEXT Oncotype DX (ODX) is a widely used commercial assay that estimates the risk of distant recurrence and may predict the… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2010
2010
The use of clinicopathologic features in decision-making in early stage estrogen receptor (ER)-positive breast cancer (BC) may… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2006
2006
1. I n t r o d u c t i o n This work is devoted to the study of the unique continuation property for second order parabolic… (More)
Is this relevant?
1999
1999
We examined the effects of sex steroid milieu on plasma leptin levels in adult male and female rats. Since the body weight is… (More)
Is this relevant?